Sarcoma Genomics – Felix Haglund de Flon's Group

The Sarcoma Genomics research group is focused on biomarker discovery and investigating the tumor biology of sarcoma. We strive to advance precision medicine and improve outcomes for sarcoma patients.

Part of the:

Our research

Our research focuses on sarcoma genomics, integrating clinical, translational, and preclinical studies to improve diagnostics and treatment strategies. We aim to identify novel biomarkers, tumor subtypes, and therapeutic targets through whole-genome and transcriptome sequencing (WGTS) and methylation profiling.

Selected collaborations

  • Basel University Hospital, Switzerland
  • Lund University, Sweden
  • Harvard University, USA
  • Memorial Sloan Kettering Cancer Center, USA
  • Scandinavian Sarcoma Group

Publications

Selected publications

Funding

  • Cancerfonden
  • The Cancer Society in Stockholm
  • The Swedish Childhood Cancer Foundation
  • The Swedish Society of Medicine
  • The Swedish Sarcoma Society

Staff and contact

Group leader

All members of the group

Dissertations

Yi Chen
Genetic and molecular mechanisms of sarcomas 
4 March 2022
Abstract

Yifan Zhang 
Morphologic and genetic features of sarcomas: improving diagnosis and exploring biomarkers
23 September 2023
Abstract

Ahmed Waraky
Insulin-like growth factor 1 receptor, novel functions and future possibilities
22 September 2017
Abstract